share_log

B of A Securities Reinstates Buy on Gilead Sciences, Announces $109 Price Target

Benzinga ·  Dec 10, 2024 20:24  · Ratings

B of A Securities analyst Tim Anderson reinstates Gilead Sciences (NASDAQ:GILD) with a Buy and announces $109 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment